Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Los Angeles, California--(Newsfile Corp. - May 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 through March 31,
San Francisco, California--(Newsfile Corp. - May 10, 2021) - Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now.Class Period: July
Los Angeles, California--(Newsfile Corp. - May 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Emergent BioSolutions Inc.
04:09pm, Saturday, 08'th May 2021
Radnor, Pennsylvania--(Newsfile Corp. - May 8, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Emergent
EBS Investor Alert: Shareholder Class Action Lawsuit Filed
09:00am, Saturday, 08'th May 2021
Boston, Massachusetts--(Newsfile Corp. - May 8, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Emergent BioSolutions Inc. (NYSE:
RADNOR, Pa., May 7, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") investors that a securities fraud class actio
Los Angeles, California--(Newsfile Corp. - May 7, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions
New York, New York--(Newsfile Corp. - May 7, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Emergent Biosolutions Inc. (NYSE: EBS) alleg
New York, New York--(Newsfile Corp. - May 6, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Emer
Los Angeles, California--(Newsfile Corp. - May 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions
EBS LAWSUIT FILED: JAKUBOWITZ LAW PURSUES CLAIMS ON BEHALF OF EMERGENT BIOSOLUTIONS INC. SHAREHOLDERS
06:30am, Thursday, 06'th May 2021
New York, New York--(Newsfile Corp. - May 6, 2021) - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders Emergent Biosolutions Inc. (NYSE: EBS
New York, New York--(Newsfile Corp. - May 5, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Emer
San Francisco, California--(Newsfile Corp. - May 5, 2021) - Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now. Class Period: July
Emergent BioSolutions to Participate in Investor Conferences
04:05pm, Wednesday, 05'th May 2021
GAITHERSBURG, Md., May 05, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company's senior management team will participate in the following invest
